| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |